Evidence map›Paper›PMID 33860747›Full record

Observational studyEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2021

SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020.

Arnaud Fontanet, Laura Tondeur, Rebecca Grant, Sarah Temmam, Yoann Madec, Thomas Bigot, Ludivine Grzelak, Isabelle Cailleau, Camille Besombes, Marie-Noëlle Ungeheuer and 17 more

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 8 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 8 syntheses or guidelines pooled it, 109 citations in OpenAlex.

  1. Measures implemented in the school setting to contain the COVID-19 pandemic.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Pooled it
  3. SARS-CoV-2 Circulation in the School Setting: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2022
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. COVID-19 and schools. Guidelines of the French Pediatric Society.Archives de pediatrie : organe officiel de la Societe francaise de pediatrie · 2020
    Guideline
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 2 institutions in 1 country.

Arnaud FontanetEmerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France.
Laura TondeurEmerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France.
Rebecca GrantEmerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France.
Sarah TemmamPathogen Discovery Laboratory, Department of Virology, Institut Pasteur, Paris, France.
Yoann MadecEmerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France.
Thomas BigotBioinformatic and Biostatistic Hub - Computational Biology Department, Institut Pasteur, Paris, France.
Ludivine GrzelakVirus and Immunity Unit, Department of Virology, Institut Pasteur, Paris, France.
Isabelle CailleauDirection de la recherche médicale, Institut Pasteur, Paris, France.
Camille BesombesEmerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France.
Marie-Noëlle UngeheuerICAReB platform (Clinical Investigation & Access to Research Bioresources) of the Center for Translational Science, Institut Pasteur, Paris, France.
Charlotte RenaudatICAReB platform (Clinical Investigation & Access to Research Bioresources) of the Center for Translational Science, Institut Pasteur, Paris, France.
Blanca Liliana PerlazaICAReB platform (Clinical Investigation & Access to Research Bioresources) of the Center for Translational Science, Institut Pasteur, Paris, France.
Laurence ArowasICAReB platform (Clinical Investigation & Access to Research Bioresources) of the Center for Translational Science, Institut Pasteur, Paris, France.
Nathalie JollyCenter for Translational Sciences, Institut Pasteur, Paris, France.
Sandrine Fernandes PellerinCenter for Translational Sciences, Institut Pasteur, Paris, France.
Lucie KuhmelMedical Center of the Institut Pasteur, Institut Pasteur, Paris, France.
Isabelle StaropoliVaccine Research Institute, Creteil, France.
Christèle HuonPathogen Discovery Laboratory, Department of Virology, Institut Pasteur, Paris, France.
Kuang-Yu ChenRNA Biology of Influenza Virus, Department of Virology, Institut Pasteur, Paris, France.
Bernadette Crescenzo-ChaigneMolecular Genetics of RNA Viruses, Institut Pasteur, Paris, France.
Sandie MunierMolecular Genetics of RNA Viruses, Institut Pasteur, Paris, France.
Pierre CharneauLaboratoire Commun Pasteur/TheraVectys, Institut Pasteur, Paris, France.
Caroline DemeretMolecular Genetics of RNA Viruses, Institut Pasteur, Paris, France.
Timothée BruelVaccine Research Institute, Creteil, France.
Marc EloitNational Veterinary School of Alfort, Maisons-Alfort, France.
Olivier SchwartzVaccine Research Institute, Creteil, France.
Bruno HoenEmerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France.
Institut Pasteur · FRConservatoire National des Arts et Métiers · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundChildren's role in SARS-CoV-2 epidemiology remains unclear. We investigated an initially unnoticed SARS-CoV-2 outbreak linked to schools in northern France, beginning as early as mid-January 2020.AimsThis retrospective observational study documents the extent of SARS-CoV-2 transmission, linked to an affected high school (n = 664 participants) and primary schools (n = 1,340 study participants), in the context of unsuspected SARS-CoV-2 circulation and limited control measures.MethodsBetween 30 March and 30 April 2020, all school staff, as well as pupils and their parents and relatives were invited for SARS-CoV-2 antibody testing and to complete a questionnaire covering symptom history since 13 January 2020.ResultsIn the high school, infection attack rates were 38.1% (91/239), 43.4% (23/53), and 59.3% (16/27), in pupils, teachers, and non-teaching staff respectively vs 10.1% (23/228) and 12.0% (14/117) in the pupils' parents and relatives (p < 0.001). Among the six primary schools, three children attending separate schools at the outbreak start, while symptomatic, might have introduced SARS-CoV-2 there, but symptomatic secondary cases related to them could not be definitely identified. In the primary schools overall, antibody prevalence in pupils sharing classes with symptomatic cases was higher than in pupils from other classes: 15/65 (23.1%) vs 30/445 (6.7%) (p < 0.001). Among 46 SARS-CoV-2 seropositive pupils < 12 years old, 20 were asymptomatic. Whether past HKU1 and OC43 seasonal coronavirus infection protected against SARS-CoV-2 infection in 6-11 year olds could not be inferred.ConclusionsViral circulation can occur in high and primary schools so keeping them open requires consideration of appropriate control measures and enhanced surveillance.

Indexed as

COVID-19ChildCohort StudiesFranceHumansRetrospective StudiesSARS-CoV-2SchoolsCoronavirus disease 2019 (COVID-19)Emerging infectious diseasesEpidemiologySARS-CoV-2

Identifiers

PMID33860747
PMCPMC8167414
OpenAlexW3154705391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.